AU Patent

AU2013100071C4 — Device

Assigned to Novartis AG · Expires 2013-05-02 · 13y expired

What this patent protects

PAT055157-AU-Innovation3 The present invention relates to a device and in particular a syringe, more particularly to a small volume syringe such as a syringe suitable for ophthalmic injections.

USPTO Abstract

PAT055157-AU-Innovation3 The present invention relates to a device and in particular a syringe, more particularly to a small volume syringe such as a syringe suitable for ophthalmic injections.

Drugs covered by this patent

Patent Metadata

Patent number: AU2013100071C4
Jurisdiction: AU
Classification: —
Expires: 2013-05-02
Drug substance claim: No
Drug product claim: No
Assignee: Novartis AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.